NGCapital

ND Capital, formerly known as NanoDimension, is a venture capital firm established in 2002, headquartered in Woodside, California. The firm focuses on investing in disruptive technologies across the life sciences, physical sciences, and data sciences sectors. Their core belief is that significant breakthroughs will arise from the convergence of these scientific disciplines. The firm is led by founder and CEO Aymeric Sallin, who has been pivotal in steering the company towards successful investments. ND Capital supports early to mid-stage companies, particularly those developing innovative and market-disruptive technologies. Their investment strategy targets companies at the forefront of scientific advancements that hold the potential to create substantial impact. ND Capital's diverse portfolio includes investments in companies like Natron Energy, Tarveda Therapeutics, Selecta Biosciences, and SQZ Biotech. The firm has a strong track record with numerous successful exits, such as the acquisition of Serotiny by Johnson & Johnson and Icosavax's IPO. The team at ND Capital consists of experienced professionals with deep expertise in various scientific and industrial fields. This includes Senior Partner Patrick Aebischer, who has extensive experience in biotechnology and academic leadership, and Partner Eric Moessinger, who focuses on life sciences investments. ND Capital's mission is to back visionary founders and innovative startups that push the boundaries of science and technology, driving forward transformative solutions that address global challenges..